PrimeBiome Ingredients: 430 mg Blend & 500 Million CFU

How to interpret the 430 mg proprietary blend

The nine-component blend totals 430 mg per gummy, so an equal-share calculation gives 47.78 mg per component. That arithmetic describes a hypothetical distribution, not the recipe. Each actual amount remains unknown, and no single ingredient can use the full blend allocation while leaving positive amounts for the other eight ingredients.

This distinction makes the inulin comparison unusually clear. A study using 12,000 mg daily cannot be matched by a gummy whose entire botanical and prebiotic blend weighs 430 mg. Dividing 430 by 12,000 gives 3.58%; the actual inulin percentage is smaller because the rest of the blend must also fit. Micka et al. (2017), PMID: 27492975 [2]

The result is a mass constraint, not a measured shortfall for every ingredient. It does not tell us which botanical is most abundant beyond the disclosed listing, whether any ingredient is active at a smaller amount, or how the complete mixture behaves. It simply prevents an implausible claim that the gummy supplies the studied 12 g of inulin.

• Use 430 mg as the combined allocation, not as the dose of each botanical.
• Do not convert CFU to milligrams: viable organism count and mass are different measurements.
• Do not interpret 47.78 mg as nine equal label servings.
• Do not take extra gummies to close a calculated gap; all other ingredients would rise too.

Ingredient evidence needs matching preparations

The clearest human comparisons involve B. coagulans and chicory inulin, but neither matches the published gummy specification. Majeed’s trial used MTCC 5856 at 2 billion CFU daily, while the label lists 500 million CFU without a strain. Inulin was studied at gram-scale intake, above this product’s entire blend mass.

A named species is a broad starting point. The letters and numbers after it identify the studied strain; they are not optional marketing decoration. Without that identifier, a reader cannot establish whether the organism is the same as the one tested. A larger count alone would not repair an identity mismatch. NCCIH [5]

The botanicals raise additional preparation questions. Babchi powder is not purified topical bakuchiol. A leaf extract is not automatically interchangeable with leaf powder, and a mushroom powder is not necessarily the standardized extract used elsewhere. The relevant question is not simply whether an ingredient has ever appeared in a paper, but whether the preparation and endpoint apply here.

For study design and outcomes, continue to the effectiveness analysis. This label audit establishes what can be compared, rather than repeating every claim about what the combination may do.

Other ingredients, sugars and dietary screening

The panel lists glucose syrup, water, sucrose, natural flavors, apple pectin, citric acid, trisodium citrate, black carrot extract, vegetable oil and carnauba wax. Nutrition values are 4 calories, 2 g carbohydrate and 1 g total sugar per gummy. Less than 1 g added sugars does not mean a sugar-free product.

If an allergy, strict dietary restriction or sensitivity affects your choice, ask about the ambiguous ingredients directly. Do not use the “No Allergens” wording to override a known reaction to a listed botanical. Keep the ingredient list available when discussing symptoms or compatibility with a professional. PrimeBiome (2026) [1] NCCIH (2025) [6]

Questions worth taking to a clinician or the supplier

A useful discussion starts with the exact panel and your intended outcome, not the promise of ten beneficial ingredients. Ask for the strain, viable-count guarantee timing, individual blend quantities and babchi specification. Those details would make the comparison more informative; a general facility badge cannot substitute for missing identity and exposure information.

• Which exact B. coagulans strain is used, and is the declared CFU count guaranteed through expiry or only at manufacture?
• What are the individual quantities and standardized constituents of the nine blend components?
• What botanical identity and psoralen testing support the babchi ingredient?
• Is a current independent finished-product testing report available, covering identity and relevant contaminants?
• Do my medicines or conditions make any ingredient inappropriate, even if its amount is not disclosed?

An independent quality report can address whether a batch matches specified contents, while a clinical trial addresses outcomes in participants. These are complementary forms of evidence. Neither an FDA facility statement nor a study of an isolated ingredient answers both questions. FDA (2026) [7] USP [8]

For symptoms, precautions and medicine questions, use the dedicated safety article. For the wider context, browse the Beauty & Personal Care Guide and Ingredients hub.

Five questions about the PrimeBiome ingredient label

These answers focus on interpreting the panel rather than predicting results. The 500 million CFU declaration, 430 mg total and one-gummy serving are useful facts, but leave important gaps. Distinguish a value actually printed on the label from an average, a marketing adjective or a study amount borrowed from another preparation.

Explore the PrimeBiome audit series

The five articles separate the overall purchase from four deeper questions. Use the main review for package value and the overall score, then choose the label, clinical evidence, safety or complaints page for its specific analysis. All figures use the same dated source record, while each article owns a distinct decision.